Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for RIZATRIPTAN

Ingredient

RIZATRIPTAN

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
RIZATRIPTAN RDT	5MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2017-07-28	2017-10-12	17458
RIZATRIPTAN RDT	10MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2018-05-07	2018-10-19	48666
SANDOZ RIZATRIPTAN ODT	10MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2022-10-04	2022-10-20	171080
SANDOZ RIZATRIPTAN ODT	10MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2021-11-24	2021-11-30	149880
SANDOZ RIZATRIPTAN ODT	5MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2025-05-05	2025-07-15	256673
SANDOZ RIZATRIPTAN ODT	10MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2024-02-20	2024-03-12	219984
SANDOZ RIZATRIPTAN ODT	10MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2025-03-10	2025-03-18	252241
SANDOZ RIZATRIPTAN ODT	5MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2024-01-23	2024-04-04	217053
SANDOZ RIZATRIPTAN ODT	5MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2025-01-13	2025-04-01	247620
SANDOZ RIZATRIPTAN ODT	5MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2019-12-10	2020-01-22	100833

Previous
1
…
5
6
7
8
9
Next

Showing 61 to 70 of 85

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
MINT-RIZATRIPTAN ODT	10MG	TABLET (ORALLY DISINTEGRATING)	Discontinued	2017-06-21	2017-07-01	13553

Showing 11 to 11 of 11